myeloid cells

  1. SNT Gatchaman

    Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC, 2024, Fanelli et al.

    Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves Fanelli; Petrone; Maracchioni; Chirico; Cipriani; Coppola; Malagnino; Teti; Sorace; Zordan; Vitale...
  2. SNT Gatchaman

    A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling, 2023, Hackney et al.

    A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling Altered myeloid inflammation and lymphopenia are hallmarks of severe infections. We identified the upregulated EN-RAGE gene program in airway and blood myeloid cells from patients with...
  3. SNT Gatchaman

    Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19, 2023, Hopkins et al

    Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19 Hopkins FR, Govender M, Svanberg C, Nordgren J, Waller H, Nilsdotter-Augustinsson Å, Henningsson AJ, Hagbom M, Sjöwall J, Nyström S, Larsson M Introduction: After more than two...
Back
Top Bottom